您的当前位置:首页 > 行业数据 > 预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万
图片属性
图片格式:PNG 图片大小:336KB 图片尺寸:2268*1114
同报告图片
 / 4
预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万_第1页
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
预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万_第2页
预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万_第3页
预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万_第4页
预计到2024年全球EGFRex20insNSCLC新发患者数量将达到7.4万_第5页
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
所属报告: 创新药疾病行业专题报告:EGFR ex20ins NSCLC处于突破的前夜布局正当时-231115(57页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠